RxDoctor Payments Data

Sam Akhavan, MD

Sports Medicine · Pittsburgh, PANPI 1801074711

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,794,974 of the $2,223,093 with a category attached, or 80.7%. Arthrex accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $592,475, 5.0 times the $119,027 reported in 2019. Among sports medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,223,093in general payments, 2019–2025

Across 593 payments — averaging $3748.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2.2M
  • Mid-atlantic Surgical Systems, LLC$6K
  • Heron Therapeutics, Inc.$31
  • Johnson & Johnson$24
  • Amgen$22
  • Pacira Therapeutics, Inc.$20
$49,607in research payments, 2019–2025

Across 29 payments — averaging $1710.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$26K
  • Zimmer Biomet$19K
  • Aesculap Biologics, LLC$5K

What the payments were for

  • Royalty or licence$1,794,97481%
  • Consulting fees$106,5135%
  • Speaking & faculty fees$274,00112%
  • Travel & lodging$36,9632%
  • Food & beverage$7,7210%
  • Education$2,9200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,223,093 in reported general payments places this provider in the 95th percentile of 311 sports medicine providers in Pennsylvania.

See all sports medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$66,004
Medicare patients
167
Services billed
3,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →